Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: Development and validation in 3237 patients from a single institution

Clinical Oncology

Volumn 25, Issue 11, 2013, Pages 639-646

  Chang, H ^a   Gao, J ^a   Xu, B Q ^a   Guo, S P ^a   Lu, R B ^a   Li, G ^a   Huang, S M ^a   Han, F ^a   Liu, Z G ^a   Tao, Y L ^a   Tu, Z W ^a   Chen, C ^a   Li, X H ^a,b   Xia, Y F ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Department of Ophthalmology   (China)

Author keywords

Complete blood count; Development; Disease specific survival; Nasopharyngeal carcinoma; Prognostic index; Validation

Indexed keywords

CISPLATIN; FLUOROURACIL; HEMOGLOBIN;

ANEMIA; AREA UNDER THE CURVE; ARTICLE; BLOOD CELL COUNT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NEUTROPHIL; NON INTENSITYMODULATED RADIOTHERAPY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTOSIS;

COMPLETE BLOOD COUNT; DEVELOPMENT; DISEASE-SPECIFIC SURVIVAL; NASOPHARYNGEAL CARCINOMA; PROGNOSTIC INDEX; VALIDATION;

BLOOD PLATELETS; COHORT STUDIES; FEMALE; HEMOGLOBINS; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; NEUTROPHILS; PLATELET COUNT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOM ALLOCATION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84884815200     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.07.004     Document Type: Article

References (25)

1. Adham M., Kurniawan A.N., Muhtadi A.I., et al. Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer 2012, 31(4):185-196.
2. Yu M.C., Yuan J.M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002, 12(6):421-429.
3. Wei W.I., Kwong D.L. Current management strategy of nasopharyngeal carcinoma. Clin Exp Otorhinolaryngol 2010, 3(1):1-12.
4. Yi J.L., Gao L., Huang X.D., et al. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution. Int J Radiat Oncol Biol Phys 2006, 65(1):161-168.
5. Guigay J., Temam S., Bourhis J., et al. Nasopharyngeal carcinoma and therapeutic management: the place of chemotherapy. Ann Oncol 2006, 17(Suppl. 10):x304-x307.
6. Lee A.W., Poon Y.F., Foo W., et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992, 23:261-270.
7. Wang H.Y., Sun B.Y., Zhu Z.H., et al. Eight-signature classifier for prediction of nasopharnyngeal carcinoma survival. JClin Oncol 2011, 29(34):4516-4525.
8. Li G., Gao J., Tao Y.L., et al. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chin J Cancer 2012, 31(4):197-206.
9. Talmi Y.P., Horowitz Z., Bedrin L., et al. Quality of life of nasopharyngeal carcinoma patients. Cancer 2002, 94(4):1012-1017.
10. Cho W.C. Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer 2007, 6:1.
11. Aapro M., Osterborg A., Gascón P., et al. Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol 2012, 23(8):1954-1962.
12. Rassi A., Rassi A., Little W.C., et al. Development and validation of a risk score for predicting death in Chagas' heart disease. NEngl J Med 2006, 355(8):799-808.
13. Gao J., Tao Y.L., Li G. Involvement of difference in decrease ofhemoglobin level in poor prognosis of stage I and II nasopharyngeal carcinoma: implication in outcome of radiotherapy. Int J Radiat Oncol Biol Phys 2012, 82(4):1471-1478.
14. Worldwide Prevalence of Anaemia 1993-2005. WHO Global Database on Anaemia. Geneva: World Health Organization.
15. Chen Hao-Zhu Practice of internal medicine 2009, Beijing: People's Medical Publishing House. 12th ed.
16. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44(3):837-845.
17. Tham I.W., Lin S., Pan J., et al. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer. Am J Clin Oncol 2010, 33(3):294-299.
18. Hui E.P., Ma B.B., Leung S.F., et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. JClin Oncol 2009, 27(2):242-249.
19. Kwong D.L., Pow E.H., Sham J.S., et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer 2004, 101(7):1584-1593.
20. Peng J., Wang Z., Chen W., et al. Integration of genetic signature and TNM staging system for predicting the relapse of locally advanced colorectal cancer. Int J Colorectal Dis 2010, 25(11):1277-1285.
21. Cheng S.H., Tsai S.Y., Horng C.F., et al. Aprognostic scoring system for locoregional control in nasopharyngeal carcinoma following conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006, 66:992-1003.
22. Chua D.T., Sham J.S., Hung K.N., et al. Predictive factors of tumor control and survival after radiosurgery for local failures of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006, 66:1415-1421.
23. Xu L., Pan J., Wu J., et al. Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break. Radiother Oncol 2010, 96:94-99.
24. Leung T.W., Tung S.Y., Sze W.K., et al. Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck 2005, 27:555-565.
25. Caro J.J., Salas M., Ward A., et al. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001, 91:2214-2221.